Use of Anticancer Therapies and Economic Burden Near the End of Life in Japan: Results From Claims Database

PURPOSEIn patients with cancer, aggressive treatment near the end of life (EOL) may decrease quality of life and increase medical costs. In this study, we examined the use of anticancer therapies near the EOL in Japan.METHODSWe used a commercial database of health insurance claims in Japan, to exami...

Full description

Bibliographic Details
Main Authors: Yusuke Kajimoto, Kazunori Honda, Kazuki Nozawa, Mineko Mukai, Lida Teng, Ataru Igarashi
Format: Article
Language:English
Published: American Society of Clinical Oncology 2022-11-01
Series:JCO Global Oncology
Online Access:https://ascopubs.org/doi/10.1200/GO.22.00227

Similar Items